Close

UPDATE: Arcturus Therapeutics (ARCT) PT Lowered to $16 at Goldman Sachs

March 1, 2022 7:28 AM EST Send to a Friend
(Updated - March 1, 2022 7:40 AM EST)

Goldman Sachs analyst Madhu Kumar lowered the price target on Arcturus ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login